doi: 10.3389/adar.2023.10901 Received 13 September 2022 Accepted 09 January 2023 Published 18 January 2023 Volume 3 - 2023 Edited by Emmanuel Onaivi, William Paterson University, United States Reviewed by Qing-Rong Liu, National Institute on Aging (NIH), United States Syed Ali, National Center for Toxicological Research (FDA), United States Updates Copyright 2023 Virmani
Batch verification lookup when lots are published Quality standards target purity vs lot purity Order request ask about documentation timing Format Lyophilized powder, single vial Strength 10 mg Supplier-listed target 99% (HPLC) not a lot-specific result Appearance White lyophilized powder Solubility Aqueous laboratory solvents (method-dependent
Who should avoid GHK-Cu: Patients with Wilson's disease (copper metabolism disorder), active liver disease, or who are pregnant or nursing
A group of enzymes located in the endoplasmic reticulum, known as cytochrome P-450, is the most important family of metabolizing enzymes in the liver
